E-Mail
IMAGE: City of Hope s Betty Ferrell, PhD, MA, CHPN, FAAN, FPCN, was selected by the ONS Board of Directors to receive the society s 2021 Lifetime Achievement Award. view more
Credit: City of Hope
DUARTE, Calif. With nearly half a century of outstanding contributions to the field of oncology nursing, City of Hope s Betty Ferrell, PhD, MA, CHPN, FAAN, FPCN, was selected by the ONS Board of Directors to receive the society s 2021 Lifetime Achievement Award. Ferrell is the director of the division of nursing research and education at City of Hope, principal investigator of the End-of-Life Nursing Education Consortium (ELNEC) project, and a world-renowned author and lecturer.
Lung Cancer Surgery Market Complete Analytical Report for 2029 with Key Players- Germed USA Inc , Me pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
NCCN Foundation Announces Awards for Rising Cancer Research Leaders
National Comprehensive Cancer Network s Oncology Research Program to oversee projects from early-career investigators advancing key areas for study in cancer care, such as cancer prevention, racial disparities in screening, immunotherapy, new insights in radiotherapy, and CAR T-cell therapy.
News provided by
Share this article
® today announced six new recipients for the 2021 NCCN Foundation Young Investigator Awards (YIA) Program. The honorees will receive up to $150,000 in funding, over two years, to advance important research on important issues in oncology. These early-career investigators from NCCN Member Institutions represent tomorrow s leaders for advancing cancer care. The NCCN Oncology Research Program (ORP) managed the selection process and will provide guidance and oversight for the projects over the grant duration.
email article
A ban on tanning bed use by minors could prevent thousands of cases of melanoma and save millions of dollars in healthcare costs. (
Cancer)
Researchers have developed the first cervical cancer model derived from human tissue, including normal cervical tissue and specimens from patients with different types of cervical cancer. (
Hubrecht Institute)
Following the recommendation by an independent monitoring committee, enrollment has stopped for two clinical trials evaluating the T-cell co-stimulatory agent feladilimab in combination therapy for advanced/metastatic head and neck cancer, GlaxoSmithKline announced.
The FDA authorized marketing of the first device that uses artificial intelligence for early detection of colon cancer.
NCCN Foundation announces awards for rising cancer research leaders eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.